Tevogen Inc. (TVGN) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Tevogen Inc. (TVGN) closed at USD 6.51 on 2026-10-14, a change of -78.5 % over the past year, with a market capitalization of USD 46.1M.

Tevogen Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Tevogen Inc. key figures

Previous close

USD 6.51 (2026-10-14)

1-year change

-78.5 %

Market cap

USD 46.1M

Enterprise value

USD 63.26M

P/E ratio (trailing)

-1.05

P/E ratio (forward)

n/a

EPS (trailing)

-6.74

EPS (forward)

n/a

PEG ratio

n/a

Price to book

-1.70

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

6.85

Employees

18

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Tevogen Inc.

Tevogen Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in Phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 patients with a B cell cancer indication, as well as Long COVID prevention and treatment. It is also developing TVGN 920, a preclinical trial drug for treating cervical cancer; TVGN 960, a preclinical trial drug for treating oropharyngeal cancer; TVGN 601, a preclinical trial drug for treating multiple sclerosis; TVGN 930, a preclinical trial drug for treating Epstein-Barr virus associated lymphomas; and TVGN 116, a product candidate targeted at hepatitis B. It also offers artificial intelligence platform for drug development. Tevogen Inc. was formerly known as Tevogen Bio Holdings Inc. and changed its name to Tevogen Inc. in July 2026. The company was incorporated in 2020 and is headquartered in Warren, New Jersey.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Tevogen Inc. and compare it with other stocks.